VEGFA and neoplasm: Several approaches are being explored to disrupt NRP1 function and impede tumor growth: Antibody-Based Therapies [5,80]: Monoclonal antibodies targeting NRP1 have been developed to block its interaction with VEGF and other ligands involved in angiogenesis.